OCULAR SCIENCES INC /DE/·4

Jan 7, 7:46 PM ET

KEN HURLEY 4

4 · OCULAR SCIENCES INC /DE/ · Filed Jan 7, 2005

Insider Transaction Report

Form 4
Period: 2005-01-06
KEN HURLEY
Vice President
Transactions
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-01-06$48.32/sh25,000$1,208,0000 total
    Exercise: $24.19Exp: 2012-08-05Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2005-01-06$44.01/sh12,000$528,1200 total
    Exercise: $28.50Exp: 2014-02-23Common Stock (12,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2005-01-06$59.51/sh22,500$1,338,9750 total
    Exercise: $13.00Exp: 2013-02-26Common Stock (22,500 underlying)
Footnotes (4)
  • [F1]Pursuant to the Merger Agreement, this option, which provided for vesting in four equal annual installments beginning August 5, 2003, was accelerated and canceled in exchange for $142,291.10 and 2,509 shares of Cooper common stock, having a market value of $72.51 per share.
  • [F2]Pursuant to the Merger Agreement this option, which provided for vesting in four equal annual installments beginning February 26, 2004, was accelerated and canceled in exchange for $274,968.84 and 4,848 shares of Cooper common stock, having a market value of $72.51 per share.
  • [F3]Pursuant to the Merger Agreement, this option, which provided for vesting in four equal annual installments beginning February 23, 2005, was accelerated and canceled in exchange for $113,900 and 2,008 shares of Cooper common stock,having a market value of $72.51 per share.
  • [F4]This combination of cash and Cooper common stock represents the per share value of the merger consideration ($72.51 per share) minus the exercise price of the option, multiplied by the number of shares of issuer common stock subject to such option.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -